Johnson & Johnson Launches First and Only Daily Disposable Multifocal Toric Contact Lens - ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM
World's leading* contact lens brand ACUVUE brings pioneering innovation for astigmatic patients with presbyopia, providing visual clarity and comfort1
Launch reinforces Johnson & Johnson's position as world leader in contact lenses* – pushing boundaries in optical and material science
JACKSONVILLE, Fla., June 23, 2025 /CNW/ -- Today, Johnson & Johnson,† a global leader in eye health, announced the launch of ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM, the first and only daily disposable contact lens for people with both astigmatism and presbyopia.2 This pioneering contact lens provides patients crisp, clear, stable vision at all distances and in all lighting conditions, along with comfort that lasts all day.1 The lens is now available in the U.S. and Canada, and the launch of ACUVUE OASYS MAX 1-Day for ASTIGMATISM is expected later this summer.
Experience the full interactive Multichannel News Release here: https://www.multivu.com/johnson-and-johnson/9332851-en-johnson-and-johnson-acuvue-oasys-max-1-day-multifocal-astigmatism
"Building on our legacy of firsts, we are thrilled to launch ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM," said Peter Menziuso, Company Group Chairman, Vision at Johnson & Johnson.‡ "ACUVUE is the world's leading contact lens brand* and with these new products, we now have the first and only complete family of daily-disposable contact lenses.# 2 Clear sight empowers people to live their best lives, and we believe everyone should have the opportunity to achieve it. That's why we focus our innovation on areas with the greatest unmet needs for patients. Today, we are working to fulfill that promise, providing millions of patients with a differentiated ACUVUE experience."
"Finally, patients with both presbyopia and astigmatism can enjoy the freedom and comfort of a daily disposable lens without compromising the quality of their vision," said Dr. Mark Wells, "This new lens was designed to help patients who struggle with multiple vision correction issues, allowing them to experience the comfort and clarity of MAX."1
Based on extensive studies, 95% of people wearing ACUVUE OASYS MAX 1-DAY MULTIFOCAL for ASTIGMATISM contact lenses reported their vision was clear during their daily activities,§ 1 while 87% saw clearly while driving at night.§ 1 Additionally, 92% of wearers said their eyes felt comfortable throughout the entire day.¶ 1
Astigmatism affects about 50% of the population,3 making it one of the most common vision conditions. It is characterized by imperfections in the curvature of the eye, leading to distorted or blurred vision. Presbyopia, commonly beginning in the early to mid-40s, is the gradual loss of near vision. Traditionally, there has been a gap for people with astigmatism when they begin to experience presbyopia. They've had to make compromises by either switching from daily contact lenses to reusables, or layering reading glasses over their contact lenses.
The ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM contact lens is built with the combination of four proprietary technologies4 which enable its comfort and visual results: BLINK STABILIZED Design helps the lens stay put, so vision is not distorted or blurry when you blink or move your head.1,4 PUPIL OPTIMIZED Design helps meet presbyopic vision needs, even as you age and your vision continues to change.5 TearStable Technology helps keep the lens hydrated, facilitating end of day comfort.†† 1,6,7,8 Finally, the OptiBlue Light Filter provides 60% blue-violet light filtering, the highest in the industry.**‡‡ 7,8
Later this summer, the ACUVUE OASYS MAX 1-Day for ASTIGMATISM contact lens will launch in both the U.S. and Canada, making the ACUVUE OASYS MAX 1-Day Family of lenses the first and only complete daily disposable family of contact lenses on the market.# 2 Both ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM and ACUVUE OASYS MAX 1-Day for ASTIGMATISM are planned to be introduced in additional markets outside North America during 2025 and beyond. To learn more about ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM or to search for an eye care provider, visit https://www.acuvue.com/en-us/oasys-max/.
†About Vision at Johnson & JohnsonJohnson & Johnson has a deep legacy in developing transformational new products that improve the health of patients' eyes. We have a bold ambition: Vision Made Possible – improving sight for more than 40 million people each year. Through cutting-edge innovation, expertise in material and optical science, and advanced technologies, we are revolutionizing the way people see and experience the world. Visit us at clearvisionforyou.com, follow @JNJVision on Twitter, Johnson & Johnson | Vision on LinkedIn, and @JNJVision on Facebook.
About Johnson & JohnsonAt Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more about our MedTech sector's global scale and deep expertise in cardiovascular, orthopaedics, surgery and vision solutions at https://thenext.jnjmedtech.com. Follow us at @JNJMedTech and on LinkedIn. Johnson & Johnson Vision Care, Inc., a Johnson & Johnson Company.
* Source Euromonitor International Limited; Eyewear 2025 edition; value sales at rsp, all retail channels, 2023 data; "ACUVUE® family of brands" represents aggregated sales of the following brands: 1-day ACUVUE®, ACUVUE® OASYS, ACUVUE® VITA®, and ACUVUE®2.‡ Peter Menziuso is an employee of Johnson & Johnson#Full/complete family consists of sphere, multifocal, toric, and multifocal toric contact lenses§ Model-adjusted percent estimate¶ T3B descriptive summaries: n=171**Filtering of HEV light by contact lenses has not been demonstrated to confer any health benefit to the user, including but not limited to retinal protection, protection from cataract progression, reduced eye strain, improved contrast, improved acuity, reduced glare, improved low light vision, or improved circadian rhythm/sleep cycle. The Eye Care Professional should be consulted for more information.††Versus ACUVUE® OASYS 1-Day, Dailies Total1®, My Day®, Infuse™ and Precision 1®.‡‡Versus publicly available information for standard daily use contact lenses as of December 2023.
© Johnson & Johnson and its affiliates 2025
2025PP10152
1 JJV Data on file, 2024: Subjective Standalone Claims for ACUVUE® OASYS MAX 1-Day MULTIFOCAL Contact Lenses for ASTIGMATISM2 JJV Data on File 2025, World's First and Only Daily Disposable Multifocal Toric Contact Lens3 Young G, Sulley A & Hunt C. Prevalence of Astigmatism in Relation to Soft Contact Lens Fitting; Eye & CL, 2011: 37: 20-254 JJV Data on File: Technical Description of ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM5 JJV Data on File 2020. ACUVUE OASYS MULTIFOCAL Fit and Performance Claims6 JJV Data on File 2022. Effect on Tear Film and Evaluation of Visual Artifacts with ACUVUE® OASYS MAX 1-Day Family.7 JJV Data on File 2022. JJV Data on File 2022 TearStable™ Technology Definition.8 JJV Data on File 2022. Material Properties: 1-DAY ACUVUE® MOIST, 1-DAY ACUVUE® TruEye®, ACUVUE® OASYS 1-Day with HydraLuxe® Technology and ACUVUE® OASYS MAX 1-Day with TearStable™ Technology Brand Contact Lenses and other daily disposable contact lens brands.
Important information for contact lens wearers: ACUVUE Contact Lenses are available by prescription only for vision correction. An eye care professional will determine whether contact lenses are right for you. Although rare, serious eye problems can develop while wearing contact lenses. To help avoid these problems, follow the wear and replacement schedule and the lens care instructions provided by your eye doctor. Do not wear contact lenses if you have an eye infection, or experience eye discomfort, excessive tearing, vision changes, redness or other eye problems. If one of these conditions occurs, remove the lens and contact your eye doctor immediately. For more information on proper wear, care and safety, talk to your eye care professional, call 1-800-843-2020, or download the Patient Instruction Guides.
Cautions Concerning Forward-Looking StatementsThis press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding the launch of ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM and ACUVUE OASYS MAX 1-Day for ASTIGMATISM contact lenses. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson. Risks and uncertainties include, but are not limited to: uncertainty of commercial success; challenges to patents; competition, including technological advances, new products and patents attained by competitors; manufacturing difficulties and delays; product efficacy or safety concerns resulting in product recalls or regulatory action; changes to applicable laws and regulations, including global health care reforms; changes in behavior and spending patterns of purchasers of health care products and services; and trends toward health care cost containment. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson's most recent Annual Report on Form 10-K, including in the sections captioned "Cautionary Note Regarding Forward-Looking Statements" and "Item 1A. Risk Factors," and in Johnson & Johnson's subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson. Johnson & Johnson does not undertake to update any forward-looking statement as a result of new information or future events or developments
Media ContactErin FarleyEfarley1@its.jnj.com
Kristyna Muñozkmunoz1@its.jnj.com
Investor Contact:Sandra Eastonseaston@its.jnj.com
View original content:https://www.prnewswire.com/news-releases/johnson--johnson-launches-first-and-only-daily-disposable-multifocal-toric-contact-lens---acuvue-oasys-max-1-day-multifocal-for-astigmatism-302488186.html
SOURCE Johnson & Johnson
View original content: http://www.newswire.ca/en/releases/archive/June2025/23/c2927.html
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
41 minutes ago
- Yahoo
Reynolds Consumer Products' (NASDAQ:REYN) Returns Have Hit A Wall
There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to see a company investing more capital into its business and ideally the returns earned from that capital are also increasing. If you see this, it typically means it's a company with a great business model and plenty of profitable reinvestment opportunities. Having said that, from a first glance at Reynolds Consumer Products (NASDAQ:REYN) we aren't jumping out of our chairs at how returns are trending, but let's have a deeper look. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. To calculate this metric for Reynolds Consumer Products, this is the formula: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.13 = US$544m ÷ (US$4.8b - US$584m) (Based on the trailing twelve months to March 2025). Therefore, Reynolds Consumer Products has an ROCE of 13%. In absolute terms, that's a pretty standard return but compared to the Household Products industry average it falls behind. Check out our latest analysis for Reynolds Consumer Products Above you can see how the current ROCE for Reynolds Consumer Products compares to its prior returns on capital, but there's only so much you can tell from the past. If you'd like to see what analysts are forecasting going forward, you should check out our free analyst report for Reynolds Consumer Products . There hasn't been much to report for Reynolds Consumer Products' returns and its level of capital employed because both metrics have been steady for the past five years. This tells us the company isn't reinvesting in itself, so it's plausible that it's past the growth phase. With that in mind, unless investment picks up again in the future, we wouldn't expect Reynolds Consumer Products to be a multi-bagger going forward. This probably explains why Reynolds Consumer Products is paying out 56% of its income to shareholders in the form of dividends. Unless businesses have highly compelling growth opportunities, they'll typically return some money to shareholders. In summary, Reynolds Consumer Products isn't compounding its earnings but is generating stable returns on the same amount of capital employed. Since the stock has declined 27% over the last five years, investors may not be too optimistic on this trend improving either. Therefore based on the analysis done in this article, we don't think Reynolds Consumer Products has the makings of a multi-bagger. On a separate note, we've found 1 warning sign for Reynolds Consumer Products you'll probably want to know about. While Reynolds Consumer Products may not currently earn the highest returns, we've compiled a list of companies that currently earn more than 25% return on equity. Check out this free list here. — Investing narratives with Fair Values A case for TSXV:USA to reach USD $5.00 - $9.00 (CAD $7.30–$12.29) by 2029. By Agricola – Community Contributor Fair Value Estimated: CA$12.29 · 0.9% Overvalued DLocal's Future Growth Fueled by 35% Revenue and Profit Margin Boosts By WynnLevi – Community Contributor Fair Value Estimated: $195.39 · 0.9% Overvalued Historically Cheap, but the Margin of Safety Is Still Thin By Mandelman – Community Contributor Fair Value Estimated: SEK232.58 · 0.2% Overvalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
41 minutes ago
- Yahoo
With qualifying over, campaigning begins for municipal elections
Jun. 26—Running for office isn't cheap, and experienced politicians say the candidates who qualified for the 2025 municipal elections should be prepared for the campaign costs. Qualifying for the Aug. 26 elections ended Tuesday with 26 candidates entering Decatur's mayoral, City Council or Board of Education races. Qualifiers in five of the 11 races are unopposed, with five incumbents seeking reelection. The race to replace Mayor Tab Bowling, who is completing his second term and isn't running again, features four candidates: Billy Jackson, Kent Lawrence, Butch Matthews and Suzie Wiley. Bowling said Wednesday that he spent about $23,000 on his 2016 campaign and close to $50,000 in 2020. While his costs more than doubled, he said he was fortunate he didn't have to buy signs in the reelection campaign. District 5 Councilman Jacob Ladner, who also isn't seeking reelection, said he raised closed to $10,000, and he has about $30 left in his election account. "I spent it all on signs, door hangers, mailers, social media and a website," Ladner said. "I hired Heather Wilson as a consultant for about $1,000." Paige Bibbee has been through three campaigns. She ran unsuccessfully in 2008 for District 3 school board. She was elected to the City Council in 2016, but lost her reelection bid in 2020. Bibbee said she was more conservative than some candidates. She estimated she spent $5,000 to $6,000 on her campaigns because she didn't want to owe a contributor for a future vote on an issue. "I didn't take contributions, but I can see where someone in a council race could easily spend $9,000 or $10,000 if they solicit contributions," Bibbee said. She also said a mayoral candidate spending $50,000 on a campaign "is not out of the realm of possibility. Mayor is a pretty big step up from a city council race." All three said they see this year's campaign as different from the 2020 campaign because the previous race occurred during the COVID-19 pandemic. Going door to door, even during a hot summer campaign, has always been one of the most effective ways to campaigning, but personal contact was limited in 2020. Ladner said his campaign left a lot of door hangers and, since "most people didn't want to answer the door," he hoped he could catch them out in their yards and have a conversation. Don Kyle went through four mayoral campaigns, winning two and losing two. He spent close to $20,000 in his 2016 campaign. Kyle said he thinks door hangers were the most effective for him, particularly with the city's older residents. He said door hangers "might be the only time a resident thinks about you because they are so busy with their daily lives." While direct mail is necessary, he said it often gets lost in the junk mail that people receive. All four former or outgoing politicians agreed that it's important to take advantage of opportunities like city events and political forums to speak with people and talk about their platforms. Kyle said they tried to hit each home two or three times with a door hanger during the campaign and especially hit as many homes as possible two weekends before the election. That gives the electors plenty of time to put the election on their calendar, "so hopefully they won't forget," Kyle said. He said older residents aren't as tied in to social media, but it's a necessary tool in a campaign. "You still need to be active and constant on social media to reach the younger residents," Kyle said. While a higher percentage of older residents voted in past elections than younger voters, Kyle said he read a report this week that younger voters (ages 25-34) almost doubled in the New York City mayor's primary, which had in-person voting Tuesday. "That's amazing," Kyle said. "But trying to get younger people interested is very difficult." Kyle and Bibbee said one of the difficulties they had as incumbents was finding time to campaign while at the same time doing their job as mayor or councilwoman. "When I took the job I wanted to give it my all," Bibbee said. "I know of candidates who just abandoned their job for their campaign, and that's just not me." The upcoming municipal elections are a year later after the state Legislature passed a law in 2021 that pushed the term from four to five years, after which they will revert to every four years again. The change moves the municipal elections off of the even years when general and congressional midterm elections occur. Kyle said he's concerned that the change could create election fatigue and impact turnout, especially since he thinks municipal elections are more important than state and national elections. "I kind of wonder if people are kind of tired of elections," Kyle said. "We had the big one last year (presidential election) and the midterm is next year. It was a mistake (to move the municipal elections) because now there will be an election every three out of four years." Kyle said they moved the municipal elections because city clerks and probate judges complained that they were having trouble finding poll volunteers. Instead, he thinks they should have put the general and midterm election together with municipal elections. "That was probably too logical," Kyle said. Bowling said he doesn't think the date change will impact Decatur's turnout. He said the number of City Council and mayoral candidates shows the amount of interest in city issues. "It (the election change) might apply in the future, but right now in Decatur I think a lot of people are paying attention to the upcoming election," Bowling said. The election comes after almost two years of protests following the fatal Sept. 29, 2023, shooting of Steve Perkins by a Decatur police officer. While the city waits on the officer's murder trial, a review by a third-party consultant led to a police chief change. The city is also in the midst of growth as it tries to manage a large number of new subdivision developments and issues like build-to-rent homes and short-term rentals. Bibbee said she agrees with Bowling that this Decatur election will get plenty of attention, but said Kyle could be right about election weariness in the future. "There's so much going on in Decatur there's going to be a big push, although the turnout could depend on the weather too," Bibbee said. "The change may not impact this year, but people could have election fatigue for future elections." Bowling said he "perceives, and I could be wrong, some candidates are running on kind of an isolated agenda." He said City Council candidates should be aware that a lot of work goes into representing their districts if they're elected. — or 256-340-2432
Yahoo
42 minutes ago
- Yahoo
Philip Morris International Inc. (PM) Is The 'Best Performing Stock Of The Last Hundred Years,' Says Jim Cramer
Philip Morris International Inc. (NYSE:PM) is one of the . Philip Morris International Inc. (NYSE:PM) is one of the biggest tobacco companies in the world. Its shares have gained 51% year-to-date on the back of several catalysts such as a strong 2025 outlook and the defensive nature of the stock. Cramer has discussed Philip Morris International Inc. (NYSE:PM) several times in his show. He has commented on the firm's revenue growth rate and its efforts to rebrand itself away from being a cigarette company. Cramer is also torn about investing in Philip Morris International Inc. (NYSE:PM). While on the one hand, he believes that the firm can continue to perform well in the future, he is unwilling to invest in the stock due to the firm's products. This time around, he remarked on the split within Philip Morris International Inc. (NYSE:PM): 'Best performing stock of the last hundred years is Phillip Morris. . .But PMI has been amazing. I mean they've got half the company, house divided stands, half the company killing people, half the company trying to save people. Interesting dynamic.' Earlier this year, Cramer commented on the defensive nature of Philip Morris International Inc. (NYSE:PM)'s shares: 'Now, the consumer staples, long considered safety stocks, well, let's just say they, they aren't all that safe these days because of a host of challenges, everything from GLP-1 drugs weighing down the food business to higher prices for all sorts of commodity inputs. A man exhaling smoke from a cigarette indicating the use of tobacco products. But there's a frequent winner here among the consumer staples. It's one I won't recommend because it's got tobacco in it and that's Philip Morris, the international tobacco company. It's one of the greatest stocks of all time though.' While we acknowledge the potential of PM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Connectez-vous pour accéder à votre portefeuille
